18th International Congress on Neuromuscular Diseases (ICNMD 2024)

Western Australia boasts an illustrious track record of remarkable achievements in neuromuscular disease research, spanning from groundbreaking discoveries like the first FDA-approved treatments for Duchenne muscular dystrophy. For the upcoming ICNMD 2024, the organizing committee has made a resolute decision to center the focus on the rapidly advancing domain of precision medicine. This strategic choice aims to shine a spotlight on the recent triumphs in this area and underscore the immense potential it holds for crafting novel therapies to combat other presently untreatable neuromuscular disorders.